Verflixt! Es sieht so aus, als wenn Sie einen veralteten Browser benutzen. Wir empfehlen Ihnen dringend Ihren Browser zu aktualisieren.
Weitere Informationen über Browser und Updates finden Sie hier

Delenex Therapeutics AG

Delenex Therapeutics AG is a recently formed biotech company based in Zürich-Schlieren. It aims to deliver the next generation of antibody fragment therapeutics in diseases with high unmet medical need. Based on a validated antibody technology platform Delenex comprises a portfolio of existing project, including clinical-stage, assets with ambitious plans for new programmes in CNS disease, dermatology and other serious conditions.
To complement the team as the company operations develop, we are looking to fill a new R&D position:


Delenex Therapeutics AG

Wagistrasse 23
8952 Schlieren
Klinische Forschung